Literature DB >> 21289644

Left atrial diameter, flow-mediated dilation of brachial artery and target organ damage in Chinese patients with hypertension.

J-Z Xu1, S-Y Wu, Y-Q Yan, Y-S Xie, Y-R Ren, Z-F Yin, C-Z Shi, C-Q Wang.   

Abstract

To investigate the relationship between left atrial (LA) size, endothelial dysfunction and different markers of target organ damage (TOD), we measured left atrial diameter (LAD) and endothelial function in hypertensive patients with or without TOD. In this study, 197 patients with hypertension were divided into four groups as follows: no TOD (Group I, n=40), one TOD (Group II, n=76), two TOD (Group III, n=46) and ≥3 TOD (Group IV, n=35). Endothelial function was assessed by endothelium-dependent vasodilatation (flow-mediated dilation, FMD) of the brachial artery. We also assessed serum creatinine, the urinary albumin-creatinine ratio (UACR), the intima-media thickness (IMT) of the common carotid, carotid to femoral pulse wave velocity (cf-PWV) and left ventricular mass index (LVMI). Our results were as follows: LA size was increased in 50.8% of patients and was associated with the number of TOD. LAD was larger in the patient groups with ≥3 TOD as compared with patients with two TOD, one TOD and no TOD. FMD was lower in patients with LAD enlargement. LAD exhibited significant relationships with serum creatinine, UACR, cf-PWV, IMT and LVMI. In stepwise multivariate regression analysis, LVMI (β=0.37, P<0.001), BMI (β=0.33, P<0.001), duration of hypertension (β=0.20, P=0.001) and FMD (β=-0.17, P=0.006) were the independent predictors of LAD. FMD significantly correlated with LAD (β=-0.26, P=0.001), male sex (β=-0.23, P=0.004) and pulse pressure (PP) (β=-0.16, P<0.05). In conclusions, enlargement of LAD may be an important predictor of endothelial dysfunction and may be considered to be an indicator for evaluating TOD in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289644     DOI: 10.1038/jhh.2010.129

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

1.  Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study.

Authors:  Kyuwan Lee; Irene Kang; Wendy J Mack; Joanne Mortimer; Fred Sattler; George Salem; Janice Lu; Christina M Dieli-Conwright
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

2.  Left atrial area index predicts adverse cardiovascular events in patients with unstable angina pectoris.

Authors:  Yi-Fan Li; Wei-Hong Li; Zhao-Ping Li; Xin-Heng Feng; Wei-Xian Xu; Shao-Min Chen; Wei Gao
Journal:  J Geriatr Cardiol       Date:  2016-08       Impact factor: 3.327

3.  Arterial stiffness in assessment of impaired left atrial function.

Authors:  Ángel García-García; Luis García-Ortiz; Manuel A Gómez-Marcos
Journal:  Anatol J Cardiol       Date:  2015-10       Impact factor: 1.596

4.  The association of echocardiographic parameters on renal outcomes in chronic kidney disease.

Authors:  Tzu-Heng Huang; Hsuan Chiu; Pei-Yu Wu; Jiun-Chi Huang; Ming-Yen Lin; Szu-Chia Chen; Jer-Ming Chang
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

5.  Ultrasonography to detect cardiovascular damage in children with essential hypertension.

Authors:  Wei Liu; Cui Hou; Miao Hou; Qiu-Qin Xu; Hui Wang; Pei-Pei Gu; Ling Sun; Hai-Tao Lv; Yue-Yue Ding
Journal:  Cardiovasc Ultrasound       Date:  2021-07-21       Impact factor: 2.062

6.  Left atrial diameter and albumin with renal outcomes in chronic kidney disease.

Authors:  Szu-Chia Chen; Jer-Ming Chang; Yi-Chun Tsai; Jiun-Chi Huang; Ho-Ming Su; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Int J Med Sci       Date:  2013-03-16       Impact factor: 3.738

7.  The relation between blood pressure components and left atrial volume in the context of left ventricular mass index.

Authors:  Marta Rojek; Marek Rajzer; Wiktoria Wojciechowska; Jerzy Gąsowski; Tomasz Pizoń; Danuta Czarnecka
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.